This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

SiBio wins product access to Irish market in Abbott’s lawsuit as UPC admits mistake

By Inbar Preiss ( August 21, 2024, 09:49 GMT | Insight) -- Abbott Diabetes Care Inc., a prominent glucose-monitoring technology provider, has lost its bid to stop medical technology startup SiBio Technology Limited from selling its rival product in Ireland, according to an order from the Court of Appeal of the Unified Patent Court issued on Monday. This week’s ruling clarifies that businesses will not be able to protect their patent rights in Ireland through the UPC, until the country ratifies its participation in the EU’s UPC system that was launched last year. Abbott Diabetes Care Inc., a prominent glucose-monitoring technology provider, has lost its bid to stop medical technology startup SiBio Technology Limited from selling its rival product in Ireland, according to an order from the Court of Appeal of the Unified Patent Court issued on Monday....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections